Akebia Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| AX9.F | MDP.TO | BCRX | GUD.TO | KMDA | IRWD | |
|---|---|---|---|---|---|---|
| Market cap | 149.80M | 156.50M | 1.98B | 1.15B | 448.99M | 586.60M |
| P/E (TTM) | — | — | — | 78.0 | 20.5 | 4.6 |
| Forward P/E | -0.7 | -249.0 | 9.4 | 45.0 | 13.5 | 2.4 |
| Price/book | 6.6 | 2.3 | -4.4 | 1.4 | 1.7 | -3.6 |
| Dividend yield | — | — | — | — | 2.17% | — |
| 1-year change | −77.48% | +80.22% | +12.15% | +97.41% | +15.44% | +131.21% |
| Today | −8.53% | +1.22% | −2.39% | +2.18% | −0.89% | −2.20% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All AX9.F news ›Comparing Gilead Sciences (NASDAQ:GILD) and Akebia Therapeutics (NASDAQ:AKBA)
Posted by Defense World Staff on Oct 19th, 2026 Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) and Gilead Sciences (NASDAQ:GILD – Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast…
Akebia Therapeutics: Nicholas Grund to resign Nov. 6
The commercial chief at Akebia Therapeutics (AKBA) plans to resign for personal reasons. Stock Titan Akebia Therapeutics: Nicholas Grund to resign Nov. 6 Nicholas Grund's consulting engagement is scheduled to continue through April 30,…
Akebia Therapeutics to Conduct Investor Meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum
Yiren Digital Provides Further Update on Operations Akebia Therapeutics (AKBA) will hold investor meetings at the Virtual U.S. Bancorp I BTIG Kidney Health Forum on October 14, 2026. CEO John P. Butler, Chief R&D and Medical Officer Dr.…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com9
-
stocktitan.net2
-
defenseworld.net1
-
manilatimes.net1
-
marketbeat.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 15 articles, not a forecast.